Event Date/Time: Nov 13, 2012 End Date/Time: Nov 15, 2012
Report as Spam

Description

The meeting that is shaping the future of personalized medicine…

We are living in the age of Personalized Medicine. We need only look to the high profile approvals of recent years for proof of the power and potential of Companion Diagnostics in drug development. But the race is far from won.
Hurdles still remain, such as reimbursement, increased regulatory cooperation, selecting the best commercial partnership models, seamless biomarker validation and the use of genomic data, to name but a few. With so many questions still to answer, isn’t it time they were all addressed?
In 2012, World CDx Boston will take a more detailed look at the unanswered questions facing drug developers working with Companion Diagnostics, Dx and technology providers as well as clinicians, payers, regulators and patients.
Register now to join them at the cutting-edge of personalized medicine…
An Evolving Field, a Growing Meeting Place…
This year, World CDx Boston brings you perspectives and exclusive case studies from more CDx stakeholders than ever before. With dedicated conference streams addressing the biggest commercial, clinical and regulatory topics, plus over 20 hours of face to face networking time with your CDx peers and future partners. Develop your own comprehensive strategy for successfully developing personalized medicines by providing solutions to some of the sector’s biggest challenges. The key questions we will be answering are:
• How do we now define the ‘Gold Standard’ of the development, approval and commercialization of companion diagnostics? Where is the Personalized Medicine field headed and what does this mean for CDx stakeholders large and small?
• What does the industry still need in terms of regulatory clarity and reimbursement support? How do we work together to promote better communication and return on investment?
• What are the most exciting technology developments in the field of Personalized Medicine? Is sequencing really the future? How do we translate these leaps in technological innovation into real-world results?
• How do you turn a drug and a diagnostic test into a fruitful commercial partnership? Learn how the world’s leading companies are selecting their own business models to speed market access and share the risks and rewards.
• Where can industry improve its communication with and understanding of other CDx stakeholders? Clinicians, patient groups and payers are all represented this year, how are they really benefiting from CDx development?
To see exactly who will be answering these questions and what else will be covered you can download the draft agenda or view it online.
If you’re a drug developer: The agenda, speakers and contacts at this meeting will allow you to develop a comprehensive strategy for developing and delivering a companion diagnostic to market. Take steps to solve your commercialization/reimbursement problems. Partner with the most innovative companies at the cutting edge of Dx. Learn how you can evolve your CDx strategy to firmly establish yourself as an industry leader
If you’re a diagnostics developer: Because of the focus on drug developers’ needs, this meeting creates the perfect environment for you to network with key decision-makers. This is your best opportunity to get in front of the biggest drug developers currently looking for Dx partners and collaborators. You’ll understand the needs of your principal target market AND learn how other diagnostic developers are addressing the same issues you're facing.
If you’re an innovative technology or service provider: You’ll get to meet the world’s leading diagnostic and drug developers, all under the same roof at the same time.
If you’re a payer or healthcare provider: You’ll get to meet key contacts from drug and diagnostic companies, and get your most pressing questions addressed, including future reimbursement plans, incentives and patient care

Venue